ES8407045A1 - Un procedimiento para la preparacion de 2-cuanidino-4-imidazoliltiazoles. - Google Patents

Un procedimiento para la preparacion de 2-cuanidino-4-imidazoliltiazoles.

Info

Publication number
ES8407045A1
ES8407045A1 ES522223A ES522223A ES8407045A1 ES 8407045 A1 ES8407045 A1 ES 8407045A1 ES 522223 A ES522223 A ES 522223A ES 522223 A ES522223 A ES 522223A ES 8407045 A1 ES8407045 A1 ES 8407045A1
Authority
ES
Spain
Prior art keywords
thiazoles
guanidino
imidazolyl
amino
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES522223A
Other languages
English (en)
Other versions
ES522223A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES522223A0 publication Critical patent/ES522223A0/es
Publication of ES8407045A1 publication Critical patent/ES8407045A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Lubricants (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE 2-GUANIDINO-4-IMIDAZOLILTIAZOLES, DE FORMULA GENERAL (I).COMPRENDE LAS SIGUIENTES OPERACIONES: PRIMERA, SE HACE REACCIONAR UN OXAZOL CON UN EXCESO DE AMINA, PARA OBTENER UN 5-ACETILIMIDAZOL; SEGUNDA, SE BROMA EL 5-ACITILIMIDAZOL EN CONDICIONES ACIDAS, PARA FORMAR UN BROMOACETILIDAZOL DE FORMULA (II); Y POR ULTIMO, SE COPULA EL BROMOACETILIMIDAZOL DE FORMULA (III).DE APLICACION EN EL TRATAMIENTO DE ULCERAS EN LOS MAMIFEROS.
ES522223A 1982-05-10 1983-05-09 Un procedimiento para la preparacion de 2-cuanidino-4-imidazoliltiazoles. Expired ES8407045A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/376,486 US4435396A (en) 1982-05-10 1982-05-10 Antiulcer 2-guanidino-4-(2-substituted-amino-4-imidazolyl)thiazoles and process therefor

Publications (2)

Publication Number Publication Date
ES522223A0 ES522223A0 (es) 1984-08-16
ES8407045A1 true ES8407045A1 (es) 1984-08-16

Family

ID=23485203

Family Applications (1)

Application Number Title Priority Date Filing Date
ES522223A Expired ES8407045A1 (es) 1982-05-10 1983-05-09 Un procedimiento para la preparacion de 2-cuanidino-4-imidazoliltiazoles.

Country Status (26)

Country Link
US (1) US4435396A (es)
EP (1) EP0094191B1 (es)
JP (1) JPS58206588A (es)
KR (1) KR860000931B1 (es)
AT (1) ATE33649T1 (es)
AU (2) AU539244B2 (es)
CA (1) CA1201120A (es)
CS (1) CS252461B2 (es)
DD (1) DD209828A5 (es)
DE (1) DE3376322D1 (es)
DK (1) DK163829B (es)
EG (1) EG17029A (es)
ES (1) ES8407045A1 (es)
FI (1) FI78481C (es)
GR (1) GR79279B (es)
GT (1) GT198302123A (es)
HU (2) HU196377B (es)
IE (1) IE55229B1 (es)
IL (1) IL68630A (es)
NO (1) NO159932C (es)
NZ (1) NZ204158A (es)
PL (1) PL141199B1 (es)
PT (1) PT76662B (es)
SU (1) SU1195907A3 (es)
YU (1) YU42857B (es)
ZA (1) ZA833286B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673677A (en) * 1983-10-03 1987-06-16 Pfizer Inc. Method for treatment of gastrointestinal disorders
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4560690A (en) * 1984-04-30 1985-12-24 Pfizer Inc. 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
US4636498A (en) * 1984-10-11 1987-01-13 Pfizer Inc. Formulation of antiinflammatory drugs
US4632993A (en) * 1984-10-11 1986-12-30 Pfizer Inc. Process for making 2-guanidino-4-(2-methyl-4-imidazolyl) thiazole dihydrobromide
WO1986003203A1 (en) * 1984-11-22 1986-06-05 Yoshitomi Pharmaceutical Industries, Ltd. Thienylthiazole derivatives
US4814341A (en) * 1986-08-26 1989-03-21 Reiter Lawrence A 2-guanidino-4-(2-furyl) thiazoles as antiulcer agents
EP0259085B1 (en) * 1986-08-29 1991-08-21 Pfizer Inc. 2-guanidino-4-arylthiazoles for treatment of peptic ulcers
EP0269239B1 (en) * 1986-10-29 1994-06-08 Pfizer Inc. Processes for 2-(1-pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)thiazole and the crystalline dihydrochloride trihydrate thereof
CA2165344A1 (en) * 1993-06-15 1994-12-22 Peter C. Canning Immune stimulants in bacterial infections
PE20110843A1 (es) 2008-09-22 2011-12-08 Cayman Chem Co Derivados de 5-(1h-imidazol-5-il)-2-fenilpirimidina, como inhibidores de prostaglandina d sintasa hematopoyetica
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3519637A (en) 1966-12-06 1970-07-07 Hoffmann La Roche 1-(4-thiazolylmethyl)nitroimidazole derivatives
DE2142585A1 (de) * 1971-08-20 1973-02-22 Schering Ag 2-(5-nitro-2-thiazolyl)-benzimidazole
FR2284601A1 (fr) * 1974-09-10 1976-04-09 Inst Francais Du Petrole Composes guanidino-heterocycliques alkyles, leur preparation et leur utilisation comme additifs pour carburants et lubrifiants
US4220654A (en) 1979-06-04 1980-09-02 Merck & Co., Inc. Cyclic imidazole cyanoguanidines
US4374843A (en) * 1980-10-14 1983-02-22 Pfizer Inc. 2-Guanidino-4-heteroarylthiazoles

Also Published As

Publication number Publication date
PT76662B (en) 1986-04-16
EP0094191B1 (en) 1988-04-20
IL68630A0 (en) 1983-09-30
NO159932B (no) 1988-11-14
FI78481B (fi) 1989-04-28
DD209828A5 (de) 1984-05-23
DK163829B (da) 1992-04-06
SU1195907A3 (ru) 1985-11-30
EG17029A (en) 1992-06-30
GR79279B (es) 1984-10-22
IL68630A (en) 1987-03-31
PL141199B1 (en) 1987-07-31
FI78481C (fi) 1989-08-10
NZ204158A (en) 1986-05-09
ES522223A0 (es) 1984-08-16
ATE33649T1 (de) 1988-05-15
PT76662A (en) 1983-06-01
DE3376322D1 (en) 1988-05-26
HU196377B (en) 1988-11-28
HU190899B (en) 1986-12-28
KR860000931B1 (ko) 1986-07-19
FI831595A0 (fi) 1983-05-09
PL241840A1 (en) 1985-01-16
YU99683A (en) 1986-02-28
AU3081584A (en) 1984-11-08
GT198302123A (es) 1984-10-27
CS318483A2 (en) 1987-02-12
DK205883A (da) 1983-11-11
FI831595L (fi) 1983-11-11
ZA833286B (en) 1984-12-24
NO159932C (no) 1989-02-22
AU539244B2 (en) 1984-09-20
CA1201120A (en) 1986-02-25
DK205883D0 (da) 1983-05-09
IE831061L (en) 1983-11-10
NO831632L (no) 1983-11-11
EP0094191A1 (en) 1983-11-16
JPS58206588A (ja) 1983-12-01
US4435396A (en) 1984-03-06
IE55229B1 (en) 1990-07-04
AU566755B2 (en) 1987-10-29
KR840004745A (ko) 1984-10-24
AU1436383A (en) 1983-11-17
YU42857B (en) 1988-12-31
CS252461B2 (en) 1987-09-17

Similar Documents

Publication Publication Date Title
PT73259A (en) Process for preparing novel substituted pyrazinyl-1,2,4-oxadiazole-5-ones
ES8407045A1 (es) Un procedimiento para la preparacion de 2-cuanidino-4-imidazoliltiazoles.
YU42698B (en) Process for obtaining penicillanoyl-oxymethyl-penicillanate-1,1,1',1'-tetraoxide
DE3370494D1 (en) Aldehyde oxidase, process for its production and microorganism therefor
YU156481A (en) Process for obtaining 6-hydrazono-pyrido (2,1-b) quinazoline-11-one
DE3161613D1 (en) Process for the production of 3-mercapto-propanediol-(1,2)
YU41968B (en) Process for obtaining hypoglycemic guanylamidines
AU585116B2 (en) Process for regenerating soybeans
DE3160037D1 (en) Process for the preparation of 2,4,6-trifluorotriazine-(1,3,5)
EP0190362A4 (en) METHOD FOR TREATING CELLS.
SU1193950A1 (ru) Способ изготовления микроканальных пластин
JO1159B1 (en) Method for preparing antihistamines
DE3374683D1 (en) Process for the preparation of 6-exo-alkanoyl-1,3,3-trimethyl-bicyclo(2.2.2.)octan-2-ones
SI8110026A8 (en) PROCESS FOR PREPARING OF IFN-alfa-type POLIPEPTIDES.

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506